Advertisement
Review Article| Volume 28, ISSUE 4, P549-585, October 2012

Alcohol Withdrawal Syndrome

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rehm J.
        • Mathers C.
        • Popova S.
        • et al.
        Global burden of disease and injury and economic costs attributable to alcohol use and alcohol-use disorders.
        Lancet. 2009; 373: 2223-2233
        • Kosten T.R.
        • O'Connor P.G.
        Management of drug and alcohol withdrawal.
        N Engl J Med. 2003; 348: 1786-1795
        • Saitz R.
        Unhealthy alcohol use.
        N Engl J Med. 2005; 352: 596-607
      1. 10th special report to the US Congress on alcohol and health. US Dept of Health & Human Services, 2000
        • Harwood H.J.
        Updating estimates of the economic costs of alcohol abuse in the United States: estimates, update methods & data.
        Lewin Group for the National Institute on Alcohol Abuse & Alcoholism, 2000 (Available at:) (Accessed March 29, 2012)
        • Gold M.S.
        Alcohol, alcohol abuse and alcohol dependence.
        (#651) CME Resource, Sacramento (CA)2003
        • Holt S.
        • Stewart I.C.
        • Dixon J.M.
        • et al.
        Alcohol and the emergency service patient.
        Br Med J. 1980; 281: 638-640
        • Foy A.
        • Kay J.
        • Taylor A.
        The course of alcohol withdrawal in a general hospital.
        QJM. 1997; 90: 253-261
        • Foy A.
        • Kay J.
        The incidence of alcohol-related problems and the risk of alcohol withdrawal in a general hospital population.
        Drug Alcohol Rev. 1995; 14: 49-54
        • Marik P.
        • Mohedin B.
        Alcohol-related admissions to an inner city hospital intensive care unit.
        Alcohol Alcohol. 1996; 31: 393-396
        • Baldwin W.A.
        • Rosenfeld B.A.
        • Breslow M.J.
        • et al.
        Substance abuse related admissions to an adult intensive care unit.
        Chest. 1993; 103: 21-25
        • de Wit M.
        • Jones D.G.
        • Sessler C.N.
        • et al.
        Alcohol-use disorders in the critically ill patient.
        Chest. 2010; 138: 994-1003
        • Sarff M.C.
        • Gold J.A.
        Alcohol withdrawal syndromes in the intensive care unit.
        Crit Care Med. 2010; 38S: S494-S501
        • Moss M.
        • Burnham E.L.
        Alcohol abuse in the critically ill patient.
        Lancet. 2006; 368: 2231-2242
        • Al-Sanouri I.
        • Dikin M.
        • Soubani A.O.
        Critical care aspects of alcohol abuse.
        South Med J. 2005; 98: 372-381
        • Manwell L.B.
        • Fleming M.F.
        • Johnson K.
        • et al.
        Tobacco, alcohol and drug use in a primary care sample: 90-day prevalence and associated factors.
        J Addict Dis. 1998; 17: 67-81
        • Hayashida M.A.
        • Alterman A.I.
        • McLellan A.T.
        • et al.
        Comparative effectiveness and cost of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome.
        N Engl J Med. 1989; 320: 358-365
        • Soyka M.
        • Horak M.
        Outpatient alcohol detoxification; implementation efficacy and outcome effectiveness of a model project.
        Eur Addict Res. 2004; 10: 180-187
        • Soyka M.
        • Schmidt S.
        Outpatient alcoholism treatment—24-month outcome and predictors of outcome.
        Subst Abuse Treat Prev Policy. 2009; 4: 15-23
        • Hoffman R.S.
        • Weinhouse G.I.
        Management of moderate and severe alcohol withdrawal syndromes.
        in: Traub S.J. Grayzel J. UpToDate. UpToDate, Waltham (MA)2011 (Available at:) (Accessed March 29, 2012)
        • Soderstrom C.A.
        • Trifillis A.L.
        • Shankar B.S.
        • et al.
        Marijuana and alcohol use among 1023 trauma patients. A prospective study.
        Arch Surg. 1988; 123: 733-737
        • Spies C.D.
        • Dubisz N.
        • Neumann T.
        • et al.
        Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of prospective randomized trial.
        Crit Care Med. 1996; 24: 414-422
        • Field C.A.
        • Classen C.A.
        • O'Keefe G.
        Association of alcohol use and other high-risk behaviors among trauma patients.
        J Trauma. 2001; 50: 13-19
        • Srivatsav M.
        • Wong-McKinstry E.S.
        • Ayagari S.
        • et al.
        Review of respiratory complications in alcohol withdrawal syndrome at a public hospital.
        Crit Care Med. 2008; 36: SA69
        • Baldwin W.A.
        • Rosenfeld B.A.
        • Breslow M.J.
        • et al.
        Substance abuse related admissions to an adult intensive care unit.
        Chest. 1993; 103: 21-25
        • Mostafa S.M.
        • Murthy B.V.
        Alcohol-associated admissions to an adult intensive care unit: an audit.
        Eur J Anaesthesiol. 2002; 19: 193-196
        • Rootman D.B.
        • Mustard R.
        • Kalia V.B.
        • et al.
        Increased incidence of complications in trauma patients cointoxicated with alcohol and other drugs.
        J Trauma. 2007; 62: 755-758
        • Spies C.D.
        • Nemer B.
        • Neurmann T.
        • et al.
        Intercurrent complications in chronic alcoholic men admitted to the intensive care unit following trauma.
        Intensive Care Med. 1996; 22: 286-293
        • Silver G.M.
        • Albright J.M.
        • Schermer C.R.
        • et al.
        Adverse clinical outcomes associated with elevated blood alcohol levels at the time of burn injury.
        J Burn Care Res. 2008; 29: 784-789
        • Diaz L.E.
        • Montero A.
        • Gonzalez-Gross M.
        • et al.
        Influence of alcohol consumption on immunologic status: a review.
        Eur J Clin Nutr. 2002; 56: S50-S53
        • Fernández-Solá J.
        • Junqué A.
        • Estruch R.
        • et al.
        High alcohol intake as a risk and prognostic factor for community acquired pneumonia.
        Arch Intern Med. 1995; 155: 1649-1654
        • Ruiz M.
        • Ewig S.
        • Torres A.
        • et al.
        Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.
        Am J Respir Crit Care Med. 1999; 160: 923-929
        • Saitz R.
        • Ghali W.A.
        • Moskowitz M.A.
        The impact of alcohol-related diagnoses on pneumonia outcomes.
        Arch Intern Med. 1997; 157: 1446-1452
        • Hudson L.D.
        • Milberg J.A.
        • Anardi D.
        • et al.
        Clinical risks for development of the acute respiratory distress syndrome.
        Am J Respir Crit Care Med. 1995; 151: 293-301
        • Happel K.I.
        • Nelson S.
        Alcohol, immunosuppression, and the lung.
        Proc Am Thorac Soc. 2005; 2: 428-432
        • Pavia C.S.
        • La Mothe M.
        • Kavanaugh M.
        Influence of alcohol on antimicrobial immunity.
        Biomed Pharmacother. 2004; 58: 84-89
        • Szabo G.
        Consequences of alcohol consumption on host defense.
        Alcohol Alcohol. 1999; 34: 830-841
        • O'Brien J.M.
        • Lu B.
        • Ali N.A.
        • et al.
        Alcohol dependence is independently associated with sepsis, septic shock and hospital mortality among adult intensive care patients.
        Crit Care Med. 2007; 35: 345-350
        • Gacouin A.
        • Legay F.
        • Camus C.
        • et al.
        At-risk drinkers are at higher risk to acquire a bacterial infection during an intensive care unit stay than abstinent or moderate drinkers.
        Crit Care Med. 2008; 36: 1735-1741
        • Guarneri J.J.
        • Laurenzi G.A.
        Effect of alcohol on the mobilization of alveolar macrophages.
        J Lab Clin Med. 1968; 72: 40-51
        • de Wit M.
        • Best A.M.
        • Gennings C.
        • et al.
        Alcohol use disorders increase the risk for mechanical ventilation in medical patients.
        Alcohol Clin Exp Res. 2007; 31: 1224-1230
        • McGovern P.E.
        Uncorking the past: the quest for wine, beer and other alcoholic beverages.
        University of California Press, Berkeley (CA)2009
        • Standage T.
        A history of the world in six glasses.
        Walker & Co, New York2005
        • Martin D.
        When to say when: wine and drunkenness in ancient Rome.
        ([MA dissertation]) University of Missouri, Columbia (MO)2010
        • Lennox W.G.
        Alcohol and epilepsy.
        Q J Stud Alcohol. 1941; 11: 1-11
        • Adams F.
        The genuine works of Hippocrates.
        William Wood & Co, New York1886
        • Lennox W.G.
        John of Gaddesden on epilepsy.
        Ann Med Hist. 1939; 1: 283-307
        • Smyth A.
        Introduction.
        in: Smyth A. A pleasing sinne: drink and conviviality in 17th century England. Brewer DS, Cambridge (United Kingdom)2004: xviii
        • Earnshaw S.
        The pub in literature: England's altered state.
        Manchester University Press, Manchester (United Kingdom)2000
      2. Huss M. Alcoholismus chronicus. Eller chronisk alkoholssjukdom; ett bidrag till dyskrasiernas kännedom. Enligt egen och andras efarenhet. Stockholm (Sweden): Beckman; 1851. p. 1849–51. [in Swedish].

        • Sutton T.
        Tracts on delirium tremens, on peritonitis and some other internal inflammatory affections, and on the gout.
        James Moyes for Thomas Underwood, London1813
        • Ware J.
        Remarks on the history and treatment of delirium tremens.
        Med Commun Mass Med Soc. 1836; 5 (cited by Cutshall BJ. The Saunders-Sutton syndrome: an analysis of delirium tremens. Q J Stud Alcohol 1965;26(3):423–8): 136-194
        • Dickens C.
        Our mutual friend.
        in: Poole A. Penguin, New York1997
        • Griffith E.
        Alcohol: the world's favorite drug. Thomas Dunne Books, New York2000 (p. 73–92)
        • Peterson V.
        • Nisenholz B.
        • Robinson G.
        A nation under the influence: America's addiction to alcohol.
        Pearson Education, Boston2003
        • Djos M.G.
        Writing under the influence: alcoholism and the alcoholic perception from Hemingway to Berryman.
        Palgrave-MacMillan, New York2010
      3. Trotter T. An essay medical, philosophical, and chemical, on drunkenness and its effects on the human body. London; 1988. (Facsimile of the 1804 London edition and based on the thesis presented to Edinburgh University in 1788). Wikipedia, The Free Encyclopedia, Wikimedia Foundation. Accessed March 29, 2012.

        • Rush B.
        An inquiry into the effects of ardents spirits upon the human body and mind: with an account of the means to preventing, and of the remedies for curing them.
        Thomas Dobson, Philadelphia1808
        • Osler W.
        The principles and practice of medicine.
        D Appleton & Co, New York1895 (p. 1057–71)
        • Sellers E.M.
        • Kalant H.
        Alcohol intoxication and withdrawal.
        N Engl J Med. 1976; 294: 757-762
        • Charney D.S.
        • Mihic S.J.
        • Harris R.A.
        Hypnotics and sedatives.
        in: Brunton L.L. Lazo J.S. Parker K.L. Goodman & Gillman's pharmacological basis of therapeutics. 11th edition. McGraw Hill, New York2006: 402 (420–1)
        • Lovinger D.M.
        • Zimmerman S.A.
        • Levitin M.
        • et al.
        Trichlorethanol potentiates synaptic transmission mediated by gamma-aminobutyric acidA receptors in hippocampal neurons.
        J Pharmacol Exp Ther. 1993; 264: 1097-1103
        • Victor M.
        Treatment of alcoholic intoxication and the withdrawal syndrome.
        Psychosom Med. 1966; 28: 636-648
        • Thompson W.L.
        • Johnson A.D.
        • Maddrey W.L.
        • et al.
        Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial.
        Ann Intern Med. 1975; 82: 175-180
        • Sainsbury M.J.
        The management of delirium tremens.
        Med J Aust. 1975; 1: 15-16
        • Hart W.T.
        A comparison of promazine and paraldehyde in 175 cases of alcohol withdrawal.
        Am J Psychiatry. 1961; 118: 323-327
        • Lopez-Munoz F.
        • Ucha-Udabe R.
        • Alamo C.
        The history of barbiturates a century after their clinical introduction.
        Neuropsychiatr Dis Treat. 2005; 1: 329-343
        • Gold J.A.
        • Rimal B.
        • Nolan A.
        • et al.
        A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens.
        Crit Care Med. 2007; 35: 724-730
        • Hendey G.W.
        • Dery R.A.
        • Barnes R.L.
        • et al.
        A prospective, randomized trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal.
        Am J Emerg Med. 2011; 29: 382-385
        • Sereny G.
        • Kalant H.
        Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol-withdrawal syndrome.
        Br Med J. 1965; 1: 92-97
        • Greenblatt D.J.
        • Greenblatt M.
        Which drug for alcohol withdrawal?.
        J Clin Pharmacol. 1972; 12: 429-431
        • Kaim S.C.
        • Klett C.J.
        • Rothfeld B.
        Treatment of the acute alcohol withdrawal state: a comparison of four drugs.
        Am J Psychiatry. 1969; 125: 1640-1646
        • Knott D.H.
        • Beard J.D.
        Diagnosis and therapy of acute withdrawal from alcohol.
        Curr Psychiatr Ther. 1970; 10: 145-150
        • Greenblatt D.J.
        • Shader R.I.
        Rational use of psychotropic drugs II. Antianxiety agents.
        Am J Health Syst Pharm. 1974; 31: 1077-1080
        • Kraus M.L.
        • Gottlieb L.D.
        • Horwitz R.I.
        • et al.
        Randomized clinical trial of atenolol in patients with alcohol withdrawal.
        N Engl J Med. 1985; 313: 905-909
        • Buchsbaum D.G.
        • Buchanan R.G.
        • Centor R.M.
        • et al.
        Screening for alcohol abuse using CAGE scores and likelihood ratios.
        Ann Intern Med. 1991; 115: 774-777
        • Bush B.
        • Shaw S.
        • Cleary P.
        • et al.
        Screening for alcohol abuse using the CAGE questionnaire.
        Am J Med. 1987; 82: 231-235
        • Shaw J.M.
        • Kolesar G.S.
        • Sellers E.M.
        • et al.
        Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care.
        J Clin Psychopharmacol. 1981; 1: 382-387
        • Sullivan J.T.
        • Sykora M.
        • Schneiderman J.
        • et al.
        Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).
        Br J Addict. 1989; 84: 1353-1357
        • Wetterling T.
        • Kanitz R.-D.
        • Besters B.
        • et al.
        A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS scale).
        Alcohol Alcohol. 1997; 32: 753-760
        • Ramsay M.A.
        • Savege T.M.
        • Simpson B.R.
        • et al.
        Controlled sedation with alphaxalone-alphadolone.
        Br Med J. 1974; 2: 656-674
        • Sessler C.N.
        • Gosnell M.S.
        • Grap M.J.
        • et al.
        The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients.
        Am J Respir Crit Care Med. 2002; 166: 1338-1344
        • Simmons L.E.
        • Riker R.R.
        • Prato S.
        • et al.
        Assessing sedation during intensive care unit mechanical ventilation with the bispectral index and the sedation-agitation scale.
        Crit Care Med. 1999; 27: 1499-1504
        • Riker R.R.
        • Picard J.T.
        • Frasher G.L.
        Prospective evaluation of the sedation-agitation scale for adult critically ill patients.
        Crit Care Med. 1999; 27: 1325-1329
        • American Psychiatric Association
        Diagnostic and statistical manual of mental disorders.
        4th edition (text revision). American Psychiatric Association, Washington, DC2000
        • Ely E.W.
        • Margolin R.
        • Francis J.
        • et al.
        Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU).
        Crit Care Med. 2001; 29: 1370-1379
        • Jellinek E.M.
        The disease concept of alcoholism.
        Hillhouse, New Haven (CT)1960
        • Booth B.M.
        • Blow F.C.
        • Ludke R.L.
        • et al.
        Utilization of acute inpatient services for alcohol detoxification.
        J Ment Health Adm. 1996; 23: 366-374
        • Zacharias S.
        • Rodriguez-Garcia A.
        • Honz N.
        • et al.
        Development of an alcohol withdrawal clinical pathway: an interdisciplinary process.
        J Nurs Care Qual. 1998; 12: 9-18
        • Isabell H.
        • Fraser H.F.
        • Wikler A.
        • et al.
        An experimental study of the etiology of “rum fits” and delirium tremens.
        Q J Stud Alcohol. 1955; 16: 1-33
        • Victor M.
        • Adams R.D.
        The effect of alcohol on the nervous system.
        Res Publ Assoc Res Nerv Ment Dis. 1953; 32: 526-573
        • Carlsson C.
        • Häggendal J.
        Arterial noradrenaline levels after ethanol withdrawal.
        Lancet. 1967; 2: 889
        • Perman E.S.
        The effect of ethyl alcohol on the secretion from the adrenal medulla in man.
        Acta Physiol Scand. 1958; 44: 241-247
        • Krystal J.H.
        • Staley J.
        • Mason G.
        • et al.
        Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability and treatment.
        Arch Gen Psychiatry. 2006; 63: 957-968
        • Ticku M.K.
        • Burch T.P.
        • Davis W.C.
        The interactions of ethanol with the benzodiazepine-GABA receptor-ionophore complex.
        Pharmacol Biochem Behav. 1983; 18: 15-18
        • Buck K.J.
        • Hahner L.
        • Sikela J.
        • et al.
        Chronic ethanol treatment alters brain levels of gamma-aminobutyric acid a receptor subunit mRNAs: relationship to genetic differences in ethanol withdrawal seizure severity.
        J Neurochem. 1991; 57: 1452-1455
        • Tsai G.
        • Coyle J.T.
        The role of glutamatergic neurotransmission in the pathophysiology of alcoholism.
        Annu Rev Med. 1998; 49: 173-184
        • Biermann T.
        • Reulbach U.
        • Lenz B.
        • et al.
        N-methyl-D-aspartate 2b receptor subtype (NR2B) promoter methylation in patients during alcohol withdrawal.
        J Neural Transm. 2009; 116: 615-622
        • Haugbøl S.R.
        • Ebert B.
        • Ulrichsen J.
        Upregulation of glutamate receptor subtypes during alcohol withdrawal in rats.
        Alcohol Alcohol. 2005; 40: 89-95
        • Lutz U.C.
        Alterations of homocysteine metabolism among alcohol dependent patients—clinical, pathobiochemical and genetic aspects.
        Curr Drug Abuse Rev. 2008; 1: 47-55
        • Giacobini E.
        • Izikowitz S.
        • Wegman A.
        Urinary norepinephrine and epinephrine excretion in delirium tremens.
        Arch Gen Psychiatry. 1960; 3: 289-296
        • Klingman G.I.
        • Goodall M.
        Urinary epinephrine and levarternol excretion during acute sublethal alcohol intoxication in dogs.
        J Pharmacol Exp Ther. 1957; 121: 313-318
        • Sjoquist B.
        • Borg S.
        • Kvande H.
        Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after long-standing intoxication.
        Subst Alcohol Actions Misuse. 1981; 2: 63-72
        • Hawley R.J.
        • Major L.F.
        • Schulman E.A.
        • et al.
        CSF levels of norepinephrine during alcohol withdrawal.
        Arch Neurol. 1981; 38: 289-292
        • Hawley R.J.
        • Major L.F.
        • Schulman E.A.
        Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlates with clinical signs.
        Arch Gen Psychiatry. 1985; 42: 1056-1062
        • Borg S.
        • Czarnecka A.
        • Kvande H.
        • et al.
        Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal.
        Alcohol Clin Exp Res. 1983; 7: 411-415
        • Sellers E.M.
        • Zilm D.H.
        • Degani N.C.
        Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal.
        J Stud Alcohol. 1977; 38: 2096-2108
        • Manhem P.
        • Nilsson L.H.
        • Moberg A.
        • et al.
        Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system and clinical symptoms.
        Alcohol Clin Exp Res. 1985; 9: 238-243
        • Romero C.
        • Bugedo G.
        • Bruhn A.
        • et al.
        Experiencia preliminar del tratamiento con dexmedetomidine del estado confusional e hiperadrenergia en la unidad de cuidados intensivos.
        Rev Esp Anestesiol Reanim. 2002; 49 ([in Spanish]): 403-406
        • Baumgartner G.R.
        • Rowen R.C.
        Transdermal clonidine versus chlorodiazepoxide in alcohol withdrawal: a randomized controlled clinical trial.
        South Med J. 1991; 84: 312-321
        • Baumgartner G.R.
        • Rowen R.C.
        Clonidine vs chlordiazepoxide in the management of the acute alcohol withdrawal syndrome.
        Arch Intern Med. 1987; 147: 1223-1226
        • Yam P.C.I.
        • Forbes A.
        • Kox W.J.
        Clonidine in the treatment of alcohol withdrawal in the intensive care unit.
        Br J Anaesth. 1992; 68: 106-108
        • Baddigam K.
        • Russo P.
        • Russo J.
        • et al.
        Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients.
        J Intensive Care Med. 2005; 20: 118-123
        • Rovasalo A.
        • Tohmo H.
        • Aantaa R.
        • et al.
        Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report.
        Gen Hosp Psychiatry. 2006; 28: 362-363
        • Mayo-Smith M.F.
        Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline.
        JAMA. 1997; 278: 144-151
        • Zilm D.H.
        • Jacob M.S.
        • MacLeod S.M.
        • et al.
        Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal.
        Alcohol Clin Exp Res. 1980; 4: 400-405
        • Worner T.M.
        Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial.
        Am J Drug Alcohol Abuse. 1994; 20: 115-124
        • Mayo-Smith M.F.
        Management of alcohol intoxication and withdrawal.
        in: Ries R.K. Fiellin D.A. Miller S.C. Principles of addiction medicine. 4th edition. Lippincott Williams & Wilkins, Philadelphia2009: 559-572
        • Pich E.M.
        • Lorang M.
        • Yeganeh M.
        • et al.
        Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.
        J Neurosci. 1995; 15: 5439-5447
        • Rassnick S.
        • Heinrichs S.G.
        • Britton K.T.
        • et al.
        Microinjection of corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.
        Brain Res. 1993; 605: 25-32
        • De Witte P.
        • Pinto E.
        • Ansseau M.
        • et al.
        Alcohol and withdrawal: from animal research to clinical issues.
        Neurosci Behav Rev. 2003; 27: 189-197
        • Bannan L.T.
        • Potter J.F.
        • Beevers D.G.
        • et al.
        Effect of alcohol withdrawal on blood pressure, plasma rennin activity, aldosterone, cortisol and dopamine beta-hydroxylase.
        Clin Sci. 1984; 66: 659-663
        • Mendelson J.H.
        • Stein S.
        Serum cortisol levels in alcoholic and nonalcoholic subjects during experimentally induced ethanol intoxication.
        Psychosom Med. 1966; 28: 616-626
        • Lovinger D.M.
        • White G.
        • Weight F.F.
        Ethanol inhibits NMDA-activated ion current in hippocampal neurons.
        Science. 1989; 243: 1721-1724
        • Kumari M.
        • Ticku M.K.
        Regulation of NMDA receptors by alcohol.
        Prog Drug Res. 2000; 54: 152-189
        • Gonzales R.A.
        • Jaworski J.N.
        Alcohol and glutamate.
        Alcohol Health Res World. 1997; 2: 120-127
        • Davis K.M.
        • Wu J.Y.
        Role of glutamatergic and GABAergic systems in alcoholism.
        J Biomed Sci. 2001; 8: 7-19
        • Tsai G.E.
        • Gastfriend D.R.
        • Coyle J.T.
        The glutamatergic basis of human alcoholism.
        Am J Psychiatry. 1995; 152: 332-340
        • Tsai G.E.
        • Ragan P.
        • Chang R.
        • et al.
        Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal.
        Am J Psychiatry. 1998; 155: 726-732
        • Blevins T.
        • Mirshahi T.
        • Woodward J.J.
        Increased agonist and antagonist sensitivity of N-methyl-D-aspartate stimulated calcium flux in cultured neurons following chronic ethanol exposure.
        Neurosci Lett. 1995; 2002: 214-218
        • Nagy J.
        Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism?.
        Drugs. 2004; 7: 339-350
        • Hoffman P.L.
        • Grant K.A.
        • Snell L.D.
        • et al.
        NMDA receptors: role in ethanol withdrawal seizures.
        Ann N Y Acad Sci. 1992; 654: 52-60
        • Grant K.A.
        • Valverius P.
        • Hudspith M.
        • et al.
        Ethanol withdrawal seizures and the NMDA receptor complex.
        Eur J Pharmacol. 1990; 176: 289-296
        • Krupitsky E.M.
        • Rudenko A.A.
        • Burakov A.M.
        • et al.
        Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.
        Alcohol Clin Exp Res. 2007; 31: 604-611
        • Krystal J.H.
        • Petrakis I.L.
        • Krupisky E.
        • et al.
        NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy.
        Ann N Y Acad Sci. 2003; 1003: 176-184
        • Bleich S.
        • Degner D.
        • Bandelow B.
        • et al.
        Plasma homocysteine is a predictor of alcohol withdrawal seizures.
        Neuroreport. 2000; 11: 2749-2752
        • Bleich S.
        • Degner D.
        • Sperline W.
        • et al.
        Homocysteine as a neurotoxin in chronic alcoholism.
        Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28: 453-464
        • Volkow N.D.
        • Wang G.-J.
        • Marynard L.
        • et al.
        Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study.
        Psychiatry Res. 2002; 116: 163-172
        • Seeman P.
        • Tallerico T.
        • Ko F.
        Alcohol-withdrawn animals have a prolonged increase in dopamine D2 high receptors, reversed by general anesthesia: relation to relapse?.
        Synapse. 2004; 52: 77-83
        • Biermann T.
        • Bonsch D.
        • Reulbach U.
        • et al.
        Dopamine and N-methyl-D-aspartate receptor expression in peripheral blood of patients undergoing alcohol withdrawal.
        J Neural Transm. 2007; 114: 1081-1084
        • Gorwood P.
        • Limosin F.
        • Batel P.
        • et al.
        The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure.
        Biol Psychiatry. 2003; 53: 85-92
        • Schmidt L.G.
        • Sander T.
        Genetics of alcohol withdrawal.
        Eur Psychiatry. 2000; 15: 135-139
        • Glue P.
        • Nutt D.
        Overexcitement and disinhibition: dynamic neurotransmitter interactions in alcohol withdrawal.
        Br J Psychiatry. 1990; 157: 491-499
        • López-Muñoz L.
        • Alamo C.
        • García-García P.
        The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs.
        J Anxiety Disord. 2011; 25: 554-562
        • Caputo F.
        • Bernardi M.
        Medications acting on the GABA system in the treatment of alcoholic patients.
        Curr Pharm Des. 2010; 16: 2118-2125
        • Enoch M.A.
        The role of GABAA receptors in the development of alcoholism.
        Pharmacol Biochem Behav. 2008; 90: 95-104
        • Olsen R.W.
        GABA-benzodiazepine-barbiturate receptor interactions.
        J Neurochem. 1981; 37: 1-13
        • Amato L.
        • Minozzi A.L.
        • Vecchi S.
        • et al.
        Benzodiazepines for alcohol withdrawal.
        Cochrane Database Syst Rev. 2010; ([review]) (CD005063): 1-111
        • Saitz R.
        • O'Malley S.S.
        Pharmacotherapies for alcohol abuse: withdrawal and treatment.
        Med Clin North Am. 1997; 81: 881-907
        • Holbrook A.M.
        • Crowther R.
        • Lotter A.
        • et al.
        Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal.
        CMAJ. 1999; 160: 649-679
        • Legio L.
        • Kenna G.A.
        • Swift R.M.
        New developments for the pharmacological treatment of alcohol withdrawal: A focus on non-benzodiazepine GABAergic medications.
        Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 1106-1117
        • Martinotti G.
        • de Nicola M.
        • Frustaci A.
        • et al.
        Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized single-blind comparison trial.
        Addiction. 2010; 105: 288-299
        • Liu J.
        • Wang L.
        Baclofen for alcohol withdrawal.
        Cochrane Database Syst Rev. 2011; ([review]) (CD008502): 1-17
        • Tabakoff B.
        • Hoffman P.L.
        Neurobiology of alcohol.
        in: Galanter M. Kleber H.D. Textbook of substance abuse treatment. 3rd edition. American Psychiatric Publishing, Washington, DC2004
        • Yu D.
        • Zhang L.
        • Eisele J.L.
        • et al.
        Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.
        Mol Pharmacol. 1996; 50: 1010-1016
        • Zuo Y.
        • Kuryatov A.
        • Lindstrom J.M.
        • et al.
        Alcohol modulation of neuronal nicotinic acetylcholine receptors in alpha subunit dependent.
        Alcohol Clin Exp Res. 2002; 26: 779-784
        • Schucket M.A.
        Vulnerability factors for alcoholism.
        in: Davis K.L. Charney D. Coyle J.T. Neuropsychopharmacology: the 5th generation of progress. Lippincott Williams & Wilkins, Philadelphia2002
        • Barr C.S.
        • Newman T.K.
        • Lindell S.
        • et al.
        Interaction between the serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates.
        Arch Gen Psychiatry. 2004; 61: 1146-1152
        • Elisaf M.
        • Merkouropoulos M.
        • Tsianos E.V.
        • et al.
        Acid-base and electrolyte abnormalities in alcoholic patients.
        Miner Electrolyte Metab. 1994; 20: 274-281
        • Flink E.B.
        • Stutzman F.L.
        • Anderson A.R.
        • et al.
        Magnesium deficiency after prolonged parenteral fluid administration and after chronic alcoholism complicated by delirium tremens.
        J Lab Clin Med. 1954; 43: 169-183
        • Victor M.
        The role of hypomagnesemia and respiratory alkalosis in the genesis of alcohol-withdrawal symptoms.
        Ann N Y Acad Sci. 1973; 215: 235-248
        • Vinson D.C.
        • Menezes M.
        Admission alcohol level: a predictor of the course of alcohol withdrawal.
        J Fam Pract. 1991; 33: 161-167
        • Ferguson J.A.
        • Suelzer C.J.
        • Eckert G.J.
        • et al.
        Risk factors for delirium tremens development.
        J Gen Intern Med. 1996; 11: 410-414
        • Kraemer K.L.
        • Mayo-Smith M.F.
        • Calkins D.R.
        Independent clinical correlates of severe alcohol withdrawal.
        Subst Abus. 2003; 24: 197-209
        • Feuerlein W.
        • Reiser E.
        Parameters affecting the course and results of delirium tremens treatment.
        Acta Psychiatr Scand Suppl. 1986; s329: 120-123
        • Wojnar M.
        • Bizon Z.
        • Wasilewski D.
        The role of somatic disorders and physical injury in the development and course of alcohol withdrawal delirium.
        Alcohol Clin Exp Res. 1999; 23: 209-213
        • Schuckit M.A.
        • Tipp J.E.
        • Reich T.
        • et al.
        The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects.
        Addiction. 1995; 90: 1335-1347
        • Sullivan J.T.
        Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale.
        J Clin Psychopharmacol. 1991; 11: 291-295
        • Turner R.C.
        • Lichstein P.R.
        • Peden Jr., J.G.
        • et al.
        Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment.
        J Gen Intern Med. 1989; 4: 432-444
        • Brown C.G.
        The alcohol withdrawal syndrome.
        Ann Emerg Med. 1982; 11: 276-280
        • Carlson R.W.
        • Keske B.
        • Cortez A.
        Alcohol withdrawal syndrome: alleviating symptoms, preventing progression.
        J Crit Illn. 1998; 13: 311-317
        • Smothers B.A.
        • Yahr H.T.
        Alcohol use disorder and illicit drug use in admissions to general hospitals in the United States.
        Am J Addict. 2005; 14: 256-267
        • Ballenger J.C.
        • Post R.M.
        Kindling as a model for alcohol withdrawal syndromes.
        Br J Psychiatry. 1978; 133: 1-14
        • Monte R.
        • Rabunal R.
        • Casariego E.
        • et al.
        Clinical aspects: analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital.
        Alcohol Alcohol. 2010; 45: 151-158
        • Booth B.M.
        • Blow F.C.
        The kindling hypothesis: further evidence from a US national study of alcoholic men.
        Alcohol Alcohol. 1993; 28: 593-598
        • Wright T.
        • Myrick H.
        • Henderson S.
        • et al.
        Risk factors for delirium tremens: a retrospective chart review.
        Am J Addict. 2006; 15: 213-219
        • Breese G.R.
        • Sinha R.
        • Heilig M.
        Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.
        Pharmacol Ther. 2011; 129: 149-171
        • Helzer J.E.
        • Pryzbeck T.R.
        The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment.
        J Stud Alcohol. 1988; 49: 219-224
        • Ramsay A.
        • Vredenbrugh J.
        • Gallagher R.M.
        Recognition of alcoholism among patients with psychiatric problems in a family practice clinic.
        J Fam Pract. 1983; 17: 829-832
        • deRoux A.
        • Cavalcanti M.
        • Marcos M.A.
        • et al.
        Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia.
        Chest. 2006; 129: 1219-1225
        • Chang P.H.
        • Steinberg M.B.
        Alcohol withdrawal.
        Med Clin North Am. 2001; 85: 1191-1212
        • Behnke R.H.
        Recognition and management of alcohol withdrawal syndrome.
        Hosp Pract. 1976; 11: 79-84
        • Hecksel K.A.
        • Bostwick J.M.
        • Jaeger T.M.
        • et al.
        Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital.
        Mayo Clin Proc. 2008; 83: 274-279
        • Carlson R.W.
        • Raj J.
        Alcohol withdrawal syndrome.
        in: Kruse J.A. Fink M.P. Carlson R.W. Saunders manual of critical care. Elsevier Science, Philadelphia2003: 240-243
        • Carlson R.W.
        • Cortez A.
        • Keske B.
        Alcohol withdrawal syndrome: clinical problems.
        Snow Tiger Medical Data Base, Houston (TX)1999
        • Ahaboucha S.
        • Butterworth R.F.
        Role of endogenous benzodiazepine ligands and their GABA-A-associated receptors in hepatic encephalopathy.
        Metab Brain Dis. 2005; 20: 425-437
        • Bismuth M.
        • Funakoshi N.
        • Cadranel J.F.
        • et al.
        Hepatic encephalopathy: from pathophysiology to therapeutic management.
        Eur J Gastroenterol Hepatol. 2011; 23: 9-22
        • Shane S.R.
        • Flink E.B.
        Magnesium deficiency in alcohol addiction and withdrawal.
        Magnes Trace Elem. 1991; 10: 263-268
        • Flink E.B.
        Magnesium deficiency in alcoholism.
        Alcohol Clin Exp Res. 1986; 10: 590-594
        • Daus A.T.
        • Freeman W.M.
        • Wilson J.
        • et al.
        Clinical experience with 781 cases of alcoholism evaluated and treated on an inpatient basis by various methods.
        Int J Addict. 1985; 20: 643-650
        • Rubeiz G.J.
        • Thill-Baharozian M.
        • Hardie D.
        • et al.
        Association of hypomagnesemia and mortality in acutely ill medical patients.
        Crit Care Med. 1993; 21: 203-209
        • Yeh H.-S.
        • Dhopesh V.
        • Maany I.
        Seizures during detoxification.
        J Gen Intern Med. 1992; 7: 123
        • Alldredge B.K.
        • Lowenstein D.H.
        • Simon R.P.
        Placebo-controlled trial of intravenous diphenylhydrantoin for short-term treatment of alcohol withdrawal seizures.
        Am J Med. 1989; 87: 645-648
        • Thompson W.L.
        Management of alcohol withdrawal syndromes.
        Arch Intern Med. 1978; 138: 278-283
        • Schuckit M.A.
        Alcohol-related disorders.
        in: Sadock B.J. Sadock V.A. Ruiz P. Comprehensive textbook of psychiatry. 9th edition. Lippincott, Philadelphia2009
        • Palmstierna T.
        A model for predicting alcohol withdrawal delirium.
        Psychiatr Serv. 2001; 52: 820-823
        • Trzepacz P.T.
        • Baker R.W.
        • Greenhouse J.
        A symptom rating scale for delirium.
        Psychiatry Res. 1988; 23: 89-97
        • Bergeron N.
        • Dubois M.J.
        • Durmont M.
        • et al.
        Intensive care delirium screening checklist: evaluation of a new screening tool.
        Intensive Care Med. 2001; 27: 859-864
        • Maldonado J.R.
        Delirium in the acute care setting: characteristics, diagnosis and treatment.
        Crit Care Clin. 2008; 24: 657-722
        • Meagher D.J.
        • Trzepacz P.T.
        Motoric subtypes of delirium.
        Semin Clin Neuropsychiatry. 2000; 5: 75-85
        • Adams Wilson J.R.
        • Morandi A.
        • Girard T.D.
        • et al.
        The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness.
        Crit Care Med. 2012; 40: 835-841
        • Girard T.D.
        • Jackson J.C.
        • Pandharipande P.P.
        • et al.
        Delirium as a predictor of long-term cognitive impairment in survivors of critical illness.
        Crit Care Med. 2010; 38: 1513-1520
        • Meagher D.J.
        • O'Hanlon D.
        • O'Mahony E.
        • et al.
        Relationship between symptoms and motoric subtype of delirium.
        J Neuropsychiatry Clin Neurosci. 2000; 12: 51-56
        • Pandharipande P.P.
        • Shintani A.
        • Peterson J.
        • et al.
        Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients.
        Anesthesiology. 2006; 104: 21-26
        • Pandharipande P.P.
        • Pun B.T.
        • Herr D.T.
        • et al.
        Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.
        JAMA. 2007; 298: 2644-2653
        • Tune L.E.
        • Bylsma F.W.
        Benzodiazepine-induced and anticholinergic-induced delirium in the elderly.
        Int Psychogeriatr. 1991; 3: 397-408
        • Hshieh T.T.
        • Fong T.G.
        • Marcantonio E.R.
        • et al.
        Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence.
        J Gerontol A Biol Sci Med Sci. 2008; 63: 764-772
        • Abraham E.
        • Shoemaker W.C.
        • McCartney S.F.
        Cardiorespiratory patterns in severe delirium tremens.
        Arch Intern Med. 1985; 145: 1057-1059
        • Trevisan L.A.
        • Boutros N.
        • Petrakis I.L.
        • et al.
        Complications of alcohol withdrawal: pathophysiological insights.
        Alcohol Health Res World. 1998; 22: 61-66
        • Bonnet U.
        • Specka M.
        • Hamzavl-Abed R.
        • et al.
        Severe protracted alcohol withdrawal syndrome: prevalence and pharmacological treatment at an inpatient detoxification unit—a naturalistic study.
        Pharmacopsychiatry. 2009; 42: 76-78
        • Favazza A.R.
        • Martin P.
        Chemotherapy of delirium tremens: a survey of physicians' preferences.
        Am J Psychiatry. 1974; 131: 1031-1033
        • Moskowitz G.
        • Chalmers T.C.
        • Sacks H.S.
        • et al.
        Deficiencies of clinical trials of alcohol withdrawal.
        Alcohol Clin Exp Res. 1983; 7: 42-44
        • Amato L.
        • Minozzi S.
        • Davoli M.
        Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome.
        Cochrane Database Syst Rev. 2011; 15: 1-25
        • Golberrt T.M.
        • Sanz C.J.
        • Rose H.D.
        • et al.
        Comparative evaluation of treatments of alcohol withdrawal syndromes.
        JAMA. 1967; 201: 99-102
        • Sellers E.M.
        • Naranjo C.A.
        • Harrison M.
        • et al.
        Diazepam loading: simplified treatment of alcohol withdrawal.
        Clin Pharmacol Ther. 1983; 34: 822-826
        • Weaver M.F.
        • Hoffman H.J.
        • Johnson R.E.
        Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity.
        J Addict Dis. 2006; 25: 17-24
        • Daeppen J.B.
        • Gache P.
        • Landry U.
        • et al.
        Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial.
        Arch Intern Med. 2002; 162: 1117-1121
        • Saitz R.
        • Mayo-Smith M.F.
        • Roberts M.S.
        • et al.
        Individualized treatment for alcohol withdrawal.
        JAMA. 1994; 272: 519-523
        • Bird R.D.
        • Makela E.H.
        Alcohol withdrawal: what is the benzodiazepine of choice?.
        Ann Pharmacother. 1994; 28: 67-71
        • Miller Jr., W.C.
        • McCurdy L.
        A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome.
        Clin Ther. 1984; 6: 364-371
        • Ritson B.
        • Chick J.
        Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery.
        Drug Alcohol Depend. 1986; 18: 329-334
        • Solomon J.
        • Rouch L.A.
        • Koepke H.H.
        Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome.
        Clin Ther. 1983; 6: 52-58
        • Sellers E.M.
        • Sandor P.
        • Giles H.G.
        • et al.
        Diazepam pharmacokinetics after intravenous administration in alcohol withdrawal.
        Br J Clin Pharmacol. 1983; 15: 125-127
        • Malacrida R.
        • Fritz M.E.
        • Suter P.M.
        • et al.
        Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients.
        Crit Care Med. 1992; 20: 1123-1126
        • Riker R.R.
        • Shehabi Y.
        • Bokesch P.M.
        • et al.
        Dexmedetomidine vs midazolam for sedation of critically ill patients.
        JAMA. 2009; 301: 489-499
        • Kollef M.H.
        • Levy N.T.
        • Ahrens T.S.
        • et al.
        The use of continuous IV sedation is associated with prolongation of mechanical ventilation.
        Chest. 1998; 114: 541-548
        • Maze M.
        • Scarfini C.
        • Cavaliere F.
        New agents for sedation in the intensive care unit.
        Crit Care Clin. 2001; 17: 881-897
        • Spies C.D.
        • Otter H.E.
        • Hiske B.
        • et al.
        Alcohol withdrawal severity is decreased by symptom-oriented adjusted bolus therapy in the ICU.
        Intensive Care Med. 2003; 29: 2230-2238
        • Reoux J.P.
        • Miller K.
        Routine hospital alcohol detoxification practice compared to symptom triggered management with an objective withdrawal scale (CIWA-Ar).
        Am J Addict. 2009; 9: 135-144
        • Kahan S.
        • Petersen K.
        • Krimsley J.
        Impact of severe delirium tremens (DT) on postoperative-traumatic recovery with the application of the CIWA-Ar.
        Crit Care Med. 2010; 38: 793
        • Dill C.
        High-dose intravenous benzodiazepine.
        Acad Emerg Med. 2000; 7: 308-310
        • Hack J.B.
        • Hoffman R.S.
        • Nelson L.S.
        Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early?.
        J Med Toxicol. 2006; 2: 55-60
        • Nolop K.P.
        • Natow A.
        Unprecedented sedative requirements during delirium tremens.
        Crit Care Med. 1985; 13: 246-247
        • Wolf K.M.
        • Shaughnessy A.F.
        • Middleton D.B.
        Prolonged delirium tremens requiring massive doses of medication.
        J Am Board Fam Pract. 1993; 6: 502-504
        • Woo E.
        • Greenblatt D.J.
        Massive benzodiazepine requirements during alcohol withdrawal.
        Am J Psychiatry. 1979; 136: 821-823
        • Volicer L.
        • Biagioni T.M.
        Effect of ethanol administration and withdrawal on benzodiazepine receptor binding in the rat brain.
        Neuropharmacology. 1982; 21: 283-286
        • Morrow A.L.
        • Suzdak P.D.
        • Karanian J.W.
        • et al.
        Chronic ethanol administration alters gamma-aminobutyric acid, pentobarbital and ethanol-mediated 36Cl-uptake in cerebral cortical synaptoneurosomes.
        J Pharmacol Exp Ther. 1988; 246: 158-164
        • Nutt D.
        • Adinoff B.
        • Linnoila M.
        Benzodiazepines in the treatment of alcoholism.
        Recent Dev Alcohol. 1989; 7: 283-313
        • Marik P.E.
        Propofol: therapeutic indications and side-effects.
        Curr Pharm Des. 2004; 10: 3639-3649
        • Vasile B.
        • Rasulo F.
        • Candiani A.
        • et al.
        The pathophysiology of the propofol infusion syndrome: a simple name for a complex syndrome.
        Intensive Care Med. 2003; 29: 1417-1425
        • McCowan C.
        • Marik P.
        Refractory delirium tremens: a case series.
        Crit Care Med. 2000; 28: 1781-1784
        • Coomes T.R.
        • Smith S.W.
        Successful use of propofol in refractory delirium tremens.
        Ann Emerg Med. 1997; 30: 825-828
        • Crippen D.W.
        Strategies for managing delirium tremens in the ICU.
        J Crit Illn. 1997; 12: 140-149
        • Darrouj J.
        • Puri N.
        • Prince E.
        • et al.
        Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal.
        Ann Pharmacother. 2008; 42: 1703-1705
        • Coursin D.B.
        • Coursin D.B.
        • Maccioli G.A.
        Dexmedetomidine.
        Curr Opin Crit Care. 2001; 7: 221-226
        • Michaelsen I.H.
        • Anderson J.E.
        • Fink-Jensen A.
        • et al.
        Phenobarbital versus diazepam for delirium tremens—a retrospective study.
        Dan Med Bull. 2010; 57: A4169
        • Addolorato G.
        • Leggio L.
        • Abenavoli L.
        • et al.
        Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam.
        Am J Med. 2006; 119: 276.e13-276.e18
        • Elsing C.
        • Stremmel W.S.
        • Grenda U.
        • et al.
        Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
        Am J Drug Alcohol Abuse. 2009; 35: 189-192
        • Myrick H.
        • Malcolm R.
        • Randall P.K.
        • et al.
        A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
        Alcohol Clin Exp Res. 2009; 33: 1582-1588
        • Ait-Daoud N.
        • Malcolm Jr., R.J.
        • Johnson B.A.
        An overview of medications for treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.
        Addict Behav. 2006; 31: 1628-1649
        • Longo L.P.
        • Campbell T.
        • Hubatch S.
        Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention.
        J Addict Dis. 2002; 21: 55-64
        • Malcolm R.
        • Myrick H.
        • Brady K.T.
        • et al.
        Update on anticonvulsants for the treatment of alcohol withdrawal.
        Am J Addict. 2001; 10: 116-123
        • Romach M.K.
        • Sellers E.M.
        Management of the alcohol withdrawal syndrome.
        Annu Rev Med. 1991; 42: 323-340
        • Sampliner R.
        • Iber F.L.
        Diphenylhydantoin control of alcohol withdrawal seizures.
        JAMA. 1974; 230: 1430-1432
        • Rathlev N.K.
        • D'Onofrio G.
        • Fish S.S.
        • et al.
        The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures.
        Ann Emerg Med. 1994; 23: 513-518
        • Jacob M.S.
        • Zilm D.H.
        • MacLeod S.M.
        • et al.
        Propranolol associated confused states during alcohol withdrawal.
        J Clin Psychopharmacol. 1983; 3: 185-187
        • Wilkins A.J.
        • Jenkins W.J.
        • Steiner J.A.
        Efficacy of clonidine in treatment of alcohol withdrawal state.
        Psychopharmacology. 1983; 81: 78-80
        • Robinson B.J.
        • Robinson G.M.
        • Maling T.J.
        • et al.
        Is clonidine useful in the treatment of alcohol withdrawal?.
        Alcohol Clin Exp Res. 1989; 13: 95-98
        • Palestine M.
        • Alatorre E.
        Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide.
        Curr Ther Res Clin Exp. 1976; 20: 289-299
        • Blum K.
        • Eubanks J.D.
        • Wallace J.E.
        • et al.
        Enhancement of alcohol-withdrawal convulsions in mice by haloperidol.
        Clin Toxicol. 1976; 9: 427-434
        • Krupitsky E.M.
        • Neznanova O.
        • Masalov D.
        • et al.
        Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients.
        Am J Psychiatry. 2007; 164: 519-523
        • Mayfield D.
        • McLeod G.
        • Hall P.
        The CAGE questionnaire: validation of a new alcoholism screening instrument.
        Am J Psychiatry. 1974; 131: 1121-1123
        • Hansbrough J.F.
        • Zapata-Sirvent R.L.
        • Carroll W.J.
        • et al.
        Administration of intravenous alcohol for prevention of withdrawal in alcoholic burn patients.
        Am J Surg. 1984; 148: 266-269
        • Craft P.P.
        • Foil M.B.
        • Cunningham P.R.
        • et al.
        Intravenous ethanol for alcohol detoxification in trauma patients.
        South Med J. 1994; 87: 47-54
        • Rosenblaum M.
        • McCarty T.
        Alcohol prescription by surgeons in the prevention and treatment of delirium tremens: historic and current practice.
        Gen Hosp Psychiatry. 2002; 24: 257-259
        • Lineaweaver W.C.
        Massive doses of midazolam infusion for delirium tremens.
        Crit Care Med. 1989; 17: 597
        • Dissanaike S.
        • Halldorsson A.
        • Frezza E.E.
        • et al.
        An ethanol protocol to prevent alcohol withdrawal syndrome.
        J Am Coll Surg. 2006; 203: 186-191
        • Weinberg J.A.
        • Magnotti L.J.
        • Fischer P.E.
        • et al.
        Comparison of intravenous ethanol versus diazepam for alcohol withdrawal prophylaxis in the trauma ICU: results of a randomized trial.
        J Trauma. 2008; 64: 99-104
        • Wilkens L.
        • Ruschulte H.
        • Ruckoldt H.
        • et al.
        Standard calculation of ethanol elimination rate is not sufficient to provide ethanol substitution therapy in the postoperative course of alcohol-dependent patients.
        Intensive Care Med. 1998; 24: 459-463
        • Eggers V.
        • Tio J.
        • Neumann T.
        • et al.
        Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit.
        Intensive Care Med. 2002; 28: 1475-1482
        • Hodges B.
        • Mazur J.E.
        Intravenous ethanol for the treatment of alcohol withdrawal syndrome in critically ill patients.
        Pharmacotherapy. 2004; 24: 1578-1585
        • Muller C.A.
        • Hein J.
        Ethanol for the treatment of alcohol withdrawal symptoms: a questionable approach.
        Neurologist. 2010; 16: 211
        • Fleming M.
        • Mihic S.J.
        • Harris R.A.
        Ethanol.
        in: Brunton L.L. Lazo J.S. Parker K.L. Goodman & Gillman's the pharmacological basis of therapeutics. 11th edition. McGraw Hill, New York2006: 591-601